Award for Scientific Progress in Immunodeficiency Research
Forecasted
The Award for Scientific Progress in Immunodeficiency Research supports scientists, clinicians, and research teams studying immunodeficiencies and immunoglobulin therapy to advance understanding and potential care.
Funder: Grifols
Due Dates (Anticipated): January 2027 (Letter of Intent)
Funding Amounts: EUR 50,000 annual grant for a 24-month project
Summary: Supports innovative research on immunodeficiencies and the role of immunoglobulin therapy.
Key Information: Applicants must be scientists or clinicians aged 45 or younger.
Description
Grifols’ ASPIRE Award supports young scientists and clinicians developing innovative ideas about primary and secondary immunodeficiencies and the role of immunoglobulin therapy. Individuals and research teams are encouraged to apply for support for a 24-month project.
The award aims to advance scientific understanding with potential clinical or medical impact. Applications are assessed for scientific merit, innovation, clinical or medical impact, and the quality of the research environment.
